EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer
EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer
EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance
EDAP Secures Euro36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU
VVC Exploration Corporation Announces Application For Management Cease Trade Order And Provides Financing Update
